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Abstract
Amino terminal peptides of the general form Gly-Gly-His have been used to introduce single sites 
of metal binding and redox activity into a wide range of biomolecules to create bioactive 
compounds and conjugates capable of substrate oxidation. We report here that Gly-Gly-His-like 
peptides linked in a tandem fashion can also be generated leading to multi-metal binding arrays. 
While metal binding by the native Gly-Gly-His motif (typically to Cu2+, Ni2+, or Co2+) requires a 
terminal peptide amine ligand, previous work has demonstrated that an ornithine (Orn) residue can 
be substituted for the terminal Gly residue to allow solid-phase peptide synthesis to continue via 
the side chain N-δ. This strategy thus frees the Orn residue N-α for metal binding and permits 
placement of a Gly-Gly-His-like metal binding domain at any location within a linear, synthetic 
peptide chain. As we show here, this strategy also permits the assembly of tandem arrays of metal 
binding units in linear peptides of the form: NH2-Gly-Gly-His-[(δ)-Orn-Gly-His]n-(δ)-Orn-Gly-
His-CONH2 (where n = 0, 1, and 2). Metal binding titrations of these tandem arrays monitored by 
UV-vis and ESI-MS indicated that they bind Cu2+, Ni2+, or Co2+ at each available metal binding 
site. Further, it was found that these systems retained their ability to modify DNA oxidatively and 
to an extent greater than their parent M(II)•Gly-Gly-His. These findings suggest that the tandem 
array metallopeptides described here may function with increased efficiency as “next generation” 
appendages in the design of bioactive compounds and conjugates.
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INTRODUCTION
Amino terminal peptides of the general form Gly-Gly-His provide a strategy to introduce 
sites of metal binding and redox activity into a wide range of biomolecules to create 
compounds and conjugates capable of substrate oxidation [1]. We report here that tandem 
arrays of these metal binding units can also be synthesized leading to multi-metallated linear 
peptides capable of increased substrate oxidation. The basis for these tandem arrays, the 
parent Gly-Gly-His peptide system, was developed originally as a model of the amino-
terminal, square planar Cu(II)-chelating domain of the serum albumins [2]; these systems 
are known to bind Cu2+ and Ni2+ tightly with KD values in the range 10−16 – 10−17 [2,3] to 
form 1:1 complexes at physiological pH or above through metal chelation by the terminal 
peptide amine, two intervening deprotonated peptide amides, and the His imidazole ring 
(Fig. 1). Upon metal binding, these systems can be activated toward the oxidative 
modification of an associated substrate, e.g., nucleic acid strand scission or protein cleavage/
crosslinking [1]. Indeed, the discovery of their ability to effect the oxidative modification of 
substrates [4,5] has led to the exploitation of these tripeptides as synthetic [6–9] or 
biosynthetic [10,11] conjugates to DNA-targeted proteins and a range of additional 
biomolecules including peptides [12], low molecular weight drugs [13–15], oligonucleotides 
[16,17], PNA strands [18], and protein-targeted systems [19–22]. More recently, Gly-Gly-
His has provided a basis for the development of catalytic metallodrugs [23, 24].
Due to the requirement of a terminal peptide amine in the coordination of metal ions, the 
placement of a native Gly-Gly-His motif is limited to single, isolated units at the amino-
termini of peptides and proteins. This restriction thus decreases the versatility of this motif 
in the development of additional bioactive compounds and seemingly eliminates the possible 
incorporation of multiple metal-binding units in close proximity. To circumvent the need for 
a terminal peptide amine, a synthetic strategy was developed in this laboratory a number of 
years ago that permits a synthetic peptide to retain the metal binding, electronic, and reactive 
properties of Gly-Gly-His while also permitting its positioning at any location within a 
linear peptide chain [25,26]. In this strategy, substitution of an appropriately protected 
ornithine (Orn) residue for amino terminal Gly1, followed by selective on-resin deprotection 
of the Orn side chain N-δ, permits solid-phase peptide synthesis to continue via a (δ)-Orn 
coupling while freeing the Orn N-α to participate in creating a four coordinate metal binding 
site in the final peptide (Fig. 1). This protocol thus allows placement of a Gly-Gly-His-like 
metal binding motif at amino-terminal, interior, or carboxy-terminal positions within 
synthetic peptides.
Exploiting this earlier work, we now report that multiple units of Orn-Gly-His metal-binding 
domains can be conjugated into tandem arrays as a possible strategy to increase the 
efficiency of substrate modification. Our design led to the synthesis of model peptides (Fig. 
1) where two-to-four metal binding domains were linked together in the sequence NH2-Gly-
Gly-His-[(δ)-Orn-Gly-His]n-(δ)-Orn-Gly-His-CONH2 (where n = 0, 1, or 2). In each case, 
the α-amino group of every Orn residue is available to participate in metal ligation in a 
fashion analogous to that of free terminal amine of Gly-Gly-His [1–3]. As will be shown, 
tandem array peptides of multiple (δ)-Orn-Gly-His units can indeed bind Cu2+, Ni2+, or 
Co2+ at all available metal binding sites and remain competent to induce oxidative DNA 
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strand scission (in the presence of Ni2+ and KHSO5). Our results also indicate that these 
tandem array systems, as expected, are more efficient at inducing substrate modification 
relative to an equimolar amount of individual, non-linked metallotripeptide. Thus, these 
systems are capable of binding multiple metals and can be employed as synthetic 
bioconjugates analogous to the parent Gly-Gly-His tripeptide, albeit with increased potency.
MATERIALS AND METHODS
Peptide Synthesis
All peptides utilized in this study were synthesized manually using routine solid-phase 
protocols [27] and commercially available (Bachem) Fmoc-protected L-amino acids and 
Rink resin (200–400 mesh). For steps involving an Orn coupling, N-δ-Fmoc-N-α-Boc-L-Orn 
was used to permit selective deprotection of the N-δ-position during main-chain assembly to 
allow continued peptide coupling via this position in lieu of the N-α of this residue. Fmoc 
deprotections were carried out using 30% piperidine/70% DMF while amino acid activation 
and peptide coupling employed HOBT and diisopropylcarbodiimide. Peptides employed in 
quantitative titration experiments were synthesized with a carboxy-terminal Tyr residue that 
provided a spectroscopic tag for accurate peptide quantitation (via ε275 = 1500 cm−1M−1) 
[28]. Side chain deprotections and resin cleavages were accomplished using 95% TFA/H2O. 
Peptides were confirmed by reverse-phase HPLC and ESI-LCMS (Agilent 1100 Series) 
using a 10 min linear gradient starting with 100% H2O containing 0.1% TFA and 
completing with 95% acetonitrile containing 0.1% TFA. Values for m/z observed 
(calculated) were: Gly-Gly-His-Tyr, 1, 432.1 (431); Gly-Gly-His-(δ)-Orn-Gly-His-Tyr, 2, 
740.2 (740); Gly-Gly-His-(δ)-Orn-Gly-His-(δ)-Orn-Gly-His-Tyr, 3, 1048.3 (1048); Gly-Gly-
His-(δ)-Orn-Gly-His-(δ)-Orn-Gly-His-(δ)-Orn-Gly-His-Tyr, 4, 1357.3 (1356)]. Bulk 
purifications were carried out using HPLC and the solvent system noted above.
UV-Visible Spectroscopy
UV-visible absorbance titrations to assess the stoichiometry of peptide-metal binding were 
carried out using a Perkin Elmer UV/Vis/NIR Lambda 19 spectrophotometer and 1.0 mL 
quartz cuvettes containing 40 mM Na-cacodylate buffer, pH 7.4, and 1.0 mM peptide. 
Concentrated aqueous stocks of Cu2+ or Ni2+ were prepared gravimetrically from their 
respective chloride salts, diluted appropriately, and titrated as 3 μL aliquots into each 
cuvette. Sample absorbances were measured after each aliquot addition and mixing; samples 
were scanned or measured at λmax= 420 nm and at λmax= 525 nm for the Ni2+ and Cu2+ 
titrations, respectively. In the examination of the stoichiometry of Co-peptide binding by 
UV-vis, peptide samples were prepared as buffered 0.5 mM solutions (Tris, pH 8.0, at 7 mM 
and 11 mM for peptides 1 and 2, respectively, and 15 mM for peptides 3 and 4), purged with 
O2 gas, treated with aliquots of freshly prepared, O2-purged CoCl2 and stirred at room 
temperature overnight; these Co(III)•metallopeptide samples were scanned from 300 to 700 
nm or monitored at 430 nm for titrations.
ESI-Mass Spectrometry
ESI-MS analyses of Cu2+- and Ni2+-peptides (4) were carried out using preformed 
metallopeptides (in 40 mM Tris buffer, pH 7.4) of varied metal binding site to metal ion 
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ratios, e.g., 4:1, 4:2, 4:3 and 4:4. Preformed metallopeptides were added to a solution of 
50% acetonitrile/40 mM Tris buffer, pH 7.4, followed by analysis using an octapole LCQ 
mass spectrometer (SN 000002). LCQ tune and Excalibur software were used to analyze the 
m/z spectra; calculated spectra were obtained via a mass isotope calculator.
DNA Cleavage
DNA cleavage analyses were carried out by pre-metallating stocks of Gly-Gly-His, Gly-
Gly-His-(δ)-Orn-Gly-His and Gly-Gly-His-(δ)-Orn-Gly-His-(δ)-Orn-Gly-His with Ni(OAc)2 
at a ratio of metal to metal binding site of 1:1 (i.e., 1:1 metal:peptide for Gly-Gly-His and 
2:1 metal:peptide for Gly-Gly-His-(δ)-Orn-Gly-His) in 17 mM Na-cacodylate buffer, pH 
7.5. Aliquot volumes appropriate for the desired final reaction concentrations were 
dispensed from these preformed metallopeptide stocks into Eppendorf tubes, followed by 
the addition of ΦX174 RF DNA (30 μM base pair final concentration). After incubating all 
DNA + metallopeptide mixtures for 10 min at room temperature, cleavage reactions were 
initiated through the addition of aliquots of a freshly prepared aqueous solution of KHSO5 
[29] to the final desired concentration and to complete the final reaction volume (20 μL) in 
10 mM Na-cacodylate, pH 7.5. All reactions were quenched after 1 min through the addition 
of an EDTA-containing (15 mM final concentration) agarose gel loading buffer. Reaction 
aliquots were loaded into 0.9% agarose gels containing 0.5 μg/mL ethidium bromide and 
electrophoresed in TAE buffer at 100 volts for 2 h. Gels were visualized using a Bio-Rad 
Gel Doc system coupled to image analysis software. Quantitation of supercoiled Form I and 
nicked-circular Form II DNAs was carried out via a densitometric analysis, applying a 
correction factor of 1.47 to account for the reduced binding of ethidium bromide to Form I 
DNA.
Molecular Modeling and Simulations
Molecular modeling and simulations were carried out on the Ni(II)4•Gly-Gly-His-(δ)-Orn-
Gly-His-(δ)-Orn-Gly-His-(δ)-Orn-Gly-His system using the following software packages: 
SPARTAN '02 [30], Sybyl 7.2 [31], MacroModel 7.0 [32], and AMBER 7 [33]. Default 
settings for these programs were used unless specified otherwise. The metal bound 
Ni(II)4•Gly-Gly-His-(δ)-Orn-Gly-His-(δ)-Orn-Gly-His-(δ)-Orn-Gly-His system was 
developed from the atomic coordinates of the basic Ni(II)•Gly-Gly-His metallopeptide; 
procedures for this process and the development of missing force field parameters have been 
described [34]. The multi-metal binding system was assembled beginning with individual 
Ni(II)•Gly-Gly-His metallopeptides that were transformed into Ni(II)•Orn-Gly-His units by 
adding an Orn side chain to the first amino acid position using the automatic adding function 
in SPARTAN '02. The multi-metal binding metallopeptide was then generated via the XLEaP 
facility of AMBER by connecting three individual Ni(II)•Orn-Gly-His units via peptide 
bonds and concluding with the connection of an amino-terminal Ni(II)•Gly-Gly-His. The 
previously developed force field parameters [34] for the basic Ni(II)•Gly-Gly-His unit were 
adapted to the new multi-metal binding system and the atomic charges were obtained 
through single point energy calculations of the assembled complex in SPARTAN '02. The 
multi-metal binding system was then solvated explicitly using the TIP3P water potential 
inside a central simulation box; the box dimensions chosen ensured that solvation extended 
10 Å on all sides of the embedded multi-metal binding system. Subsequent MD simulations 
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were carried out as described previously [34] with production runs in excess of 5000 ps. 
Structures (25,000) were saved to disk during the simulation for post-processing by 
uniformly sampling the trajectory during the production run. All analyses of results were 
performed using the CARNAL and ANAL programs in AMBER.
RESULTS AND DISCUSSION
Peptide Design and Synthesis
Using the strategy outlined in Figure 1 and standard Fmoc-based solid phase peptide 
synthesis protocols, four model peptides were assembled containing one, two, three, or four 
Gly-Gly-His-like metal binding units, respectively: Gly-Gly-His-Tyr, 1; Gly-Gly-His-(δ)-
Orn-Gly-His-Tyr, 2; Gly-Gly-His-(δ)-Orn-Gly-His-(δ)-Orn-Gly-His-Tyr, 3; and Gly-Gly-
His-(δ)-Orn-Gly-His-(δ)-Orn-Gly-His-(δ)-Orn-Gly-His-Tyr, 4. Each peptide was 
synthesized containing a carboxamide-terminal Tyr residue to facilitate accurate peptide 
quantification via Tyr absorbance [28]; additional peptides without a terminal Tyr residue 
were synthesized in parallel. In the case of 1, the peptide contained an amino-terminal Gly-
Gly-His motif in the native metal binding environment and served as a control and standard 
for comparison throughout our study. All syntheses employed established Fmoc procedures 
and commercially-available, protected amino acid monomers; individual couplings 
proceeded smoothly as reported also for earlier studies that employed tBoc protocols to 
incorporate (δ)-Orn-Gly-His into linear peptide chains [25,26].
UV-Vis Spectrophotometric Analyses of Metal Binding
Peptides 1–4 were analyzed by UV-vis spectrophotometry to assess their ability to bind 
transition metals and to determine whether or not they did so stoichiometrically based on the 
number of available Gly-Gly-His-like metal binding units. As illustrated for peptide 4 (Fig. 
2, top panels), when 1 mM of peptide was titrated with Cu2+ or Ni2+, and monitored within 
the range of their expected λmax values (525 nm and 420 nm indicative of Cu2+ and Ni2+-
bound Gly-Gly-His motifs, respectively) [1–3], metal binding was indeed observed. Metal 
binding was also observed to saturate upon full occupancy of each peptide (e.g., four 
equivalents of M2+ for 4); additional equivalents of metal ion beyond full saturation did not 
result in increased sample absorbance for any peptide studied. As also illustrated (Fig. 2, top 
panels), the UV-vis spectra of peptide 4 titrated with Cu2+ or Ni2+ indicated that 
intermediate titration points all display spectral characteristics identical to that of the 
isolated, native amino-terminal Gly-Gly-His control peptide 1 when bound to Cu or Ni; 
shifts in the λmax of 4 upon metal binding were not observed relative to M(II)•1 nor 
evidence of hypo- or hyperchromicity. The λmax values and extinction coefficients 
determined for these species were the same under our conditions. Indeed, it was found that 
Gly-Gly-His-Tyr, 1, bound Cu2+ in a 1:1 stoichiometric ratio and exhibited λmax (525 nm) 
and molar extinction coefficient (90 M−1cm−1) values that were identical to the λmax and 
molar extinction coefficients for Cu(II)2•2, Cu(II)3•3, and Cu(II)4•4, on a per metal binding 
site basis; these values are comparable to literature values [2,3,25,26]. Similarly, 1 bound to 
Ni2+ with a λmax of 420 nm and exhibited a molar extinction coefficient of 98 M−1 cm−1 
while the λmax and molar extinction coefficients for Ni(II)2•2, Ni(II)3•3, and Ni(II)4•4, again 
on a per metal binding site basis, were found to be similar to each other and to literature 
Lewis et al. Page 5
Curr Bioact Compd. Author manuscript; available in PMC 2015 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
values [2]. The linearity of the observed absorbance with respect to the concentration of 
available metal binding sites suggests that each metal binding site behaves in a fashion 
similar to an isolated, metal-bound Gly-Gly-His unit.
As a further assessment of the metal binding stoichiometries of these systems, 1 mM of each 
peptide (1–4) was titrated with Cu2+ or Ni2+, and monitored at their respective λmax values 
(525 nm and 420 nm, respectively) indicative of the metal-bound peptides (Fig. 2, middle 
panels). With each model peptide, metal binding was observed to plateau upon attainment of 
full stoichiometric occupancy of all Gly-Gly-His-like motifs present in a given peptide. The 
slight deviations observed from uniformity in the final incremental absorbances attained 
upon metal binding to the four different peptide samples at saturation were found to be 
within experimental error. Consistent with the extinction coefficients presented earlier, the 
total absorbance of 1 mM Cu(II)4•4 (Fig. 2) was found to be identical to 4 mM Cu(II)•1. 
Further, given the overlapping slopes of each titration plot illustrated in Fig. 2, it is apparent 
that each available metal binding system exhibited an affinity for a given metal ion that was 
comparable to the parent control peptide 1 [3] under identical conditions. This result is in 
accord with previous studies of Orn-Gly-His metal binding [25,26] and supports the notion 
that each metal binding site is minimally impacted by the proximity of a flanking site. Thus, 
based on the results described above, it appears that each model peptide was capable of 
binding Cu2+ and Ni2+ stoichiometrically in a tetradentate manner based on the number of 
available Gly-Gly-His-like units.
Along with analyses of Cu2+ and Ni2+ binding, the formation of Co(III)-bound tandem array 
peptides was also examined. With these systems, Co2+ salts were employed to metallate 
each peptide structure followed by in situ O2 oxidation to generate Co(III)-bound 
metallopeptides that were analyzed subsequently by UV-vis absorbance spectroscopy. 
Complete oxidation of peptide-bound Co2+ to Co3+ provides a uniform basis through which 
to monitor and compare metal binding to earlier systems [35,36]. This protocol was 
employed also in the generation of monomeric Co(III)•Gly-Gly-His metallopeptides [35,36]. 
As shown in Figure 2, the final Co(III)-metallated tandem array peptide 4 exhibited 
absorbance in the visible region of the spectrum (with a maximum at 430 nm and a broader 
absorbance between 522–546 nm) consistent with Co-peptide coordination. These spectral 
features are analogous to those reported previously for Co(III)•Gly-Gly-His (λmax values at 
434 nm and 520 nm [35,36] and (NH3)2Co(III)•Gly-Gly-His-COOH (λmax values at 442 nm 
and 520 nm) [37]. Thus, as observed with Cu and Ni, Co was found to bind 
stoichiometrically to these systems (1–4) based on the number of available Gly-Gly-His-like 
motifs: metal binding attained a saturation point at 1:1 Co:metal binding site and further 
equivalents of added Co2+ (+ O2) did not influence the spectra.
ESI-MS Analyses of Metal Binding
The metal binding of our tandem array system was investigated further using ESI-MS. 
Employing peptide 4, containing four tandem-linked Gly-Gly-His-like motifs, preformed 
metal-peptide complexes were generated by combining the apo-peptide with one, two, three, 
or four equivalents of Cu2+ (or Ni2+) in 40 mM Tris buffer, pH 7.4; these metallated 
peptides were then analyzed by ESI-MS. As shown in Figure 3 for a metal:metal binding 
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site ratio of 3:4 (chosen to illustrate the presence of all species), five major clusters of m/z 
values (1356.6, 1417.5, 1478.2, 1542.2, and 1605.2) were found. These values correspond to 
apo peptide 4, Cu(II)•4, Cu(II)2•4, Cu(II)3•4, and Cu(II)4•4, respectively, and provide direct 
evidence for the binding of multiple metals simultaneously. Further, close analysis of m/z 
values clustered around m/z = 1417.5 indicate that the values present in the cluster 
correspond exactly to the predicted isotopic distribution for peptide 4 bound to a single Cu 
(shown as an expansion in Fig. 3). For analyses carried out at a metal to metal binding site 
ratio of 4:4, the m/z value of 1605 was found to predominate, while analyses of samples 
containing lower added equivalents of metal ion (1:4 and 2:4) permitted observation of the 
gradual disappearance of apo-peptide accompanied by the appearance of species of 
intermediate metal binding occupancy. Along with the Cu(II)-bound systems, the ESI-MS of 
Ni2+ bound to 4 was analyzed in an identical fashion; the values observed indicated the 
ability of 4 to bind Ni2+ stoichiometrically as observed with Cu2+ (data not shown).
The above analyses confirmed that peptides 2–4 are capable of binding to Cu2+ and Ni2+ to 
form linear arrays of tetrachelated, square-planar, or distorted square planar structures. In 
addition, as demonstrated with Co, these peptides can also accommodate to full occupancy 
transition metal ions that ultimately metallate the peptides in an exchange-inert fashion with 
final octahedral geometries.
Modeling and Simulation
To examine the likely solution structure and behavior of the multiple metal binding system 
described above, we carried out molecular simulations and modeling of Ni(II)4•Gly-Gly-
His-(δ)-Orn-Gly-His-(δ)-Orn-Gly-His-(δ)-Orn-Gly-His. Using the crystal structure of a 
monomeric system as a starting point [38], molecular dynamics (MD) simulations were 
carried out as described previously [34] with production runs in excess of 5000 ps. Initially, 
the root mean square deviation (RMSD) observed in the simulation of this system was 
examined to determine if the system had attained equilibrium; the RMSD of the oligomer-
complex with respect to its starting structure was determined to attain equilibrium after 250 
ps and the energy was found to be stable during the course of the remainder of the 
simulation. Hence, a time of 500 ps after thermal warm-up was selected as a starting point 
for data collection and analysis of the simulation trajectory.
Visual analysis of the 5 ns simulation trajectory indicated that the linear, metallated 
oligomer fluctuated from an extended conformation to a folded, hairpin conformation. As an 
evaluation of these conformational changes, the distance between the Ni ions at each 
terminus of the four metal-containing system was monitored and found to alternate between 
~ 32 Å in the most extended structures to ~ 12 Å in the folded, hairpin conformation; these 
same Ni atoms were ~ 20 Å apart in the starting structure. In the final analysis 
approximately 10% of the total snapshots obtained during the course of the simulation 
revealed the two terminal Ni atoms to be < 15 Å apart, with 22% of the structures folded to 
< 18 Å apart. Overall, the average structure of this system (Fig. 4) revealed that the total 
length of the oligomer was approximately 23 Å and that the individual metal binding 
equatorial planes were extended away from each other during most instances. While only 
speculation at this point, close examination of these models suggested that the flexibility and 
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extended nature of this system may enable it to closely align with the structure of a DNA 
minor groove, an established target for monomeric M(II)•Gly-Gly-His metallopeptides 
[1,29,34,39,40], perhaps as a consequence promoting association within the minor groove 
and the interaction of multiple metals simultaneously with the DNA target.
Assessment of Reactivity via DNA Cleavage Activity
Having confirmed the ability of peptides 2–4 to bind multiple equivalents of Cu, Ni, and Co, 
the impact of metal binding site linkage on the reactivity of these systems was assessed in 
comparison to monomeric M(II)•Gly-Gly-His units through a test of their DNA cleavage 
competence [29,34]. It is well established that Ni(II)•Gly-Gly-His peptides can be activated 
oxidatively to cleave DNA through the use of KHSO5 or other agents [29,34,39]; a standard 
test for the ability of such agents to cleave DNA involves monitoring the conversion of 
supercoiled (Form I) plasmid DNA into cleaved, nicked-circular (Form II) DNA and linear 
(Form III) DNA [25]. As shown in Figure 5, a side-by-side comparison of the ability of 
Ni(II)•Gly-Gly-His, Ni(II)2•Gly-Gly-His-(δ)-Orn-Gly-His and Ni(II)3•Gly-Gly-His-(δ)-Orn-
Gly-His-(δ)-Orn-Gly-His to convert supercoiled Form I DNA to nicked-circular Form II 
DNA upon activation with KHSO5 [29,34] indicated that Ni(II)2•Gly-Gly-His-(δ)-Orn-Gly-
His and Ni(II)3•Gly-Gly-His-(δ)-Orn-Gly-His-(δ)-Orn-Gly-His remained active towards 
DNA cleavage in a fashion similar to Ni(II)•Gly-Gly-His; while Form II DNA was formed 
exclusively in this particular analysis, linear, Form III DNA was observed at higher 
metallopeptide concentrations (data not shown). Interestingly, a comparison of lanes 6, 7 
and 8 indicated that the Orn-linked systems consistently cleaved DNA to an extent greater 
than Ni(II)•Gly-Gly-His on a per metal basis; each of these lanes contained an identical 
amount of Ni-bound peptide. Indeed, densitometric analysis of the DNA cleavage induced 
by Ni(II)3•Gly-Gly-His-(δ)-Orn-Gly-His-(δ)-Orn-Gly-His indicated the generation of 64% 
Form II DNA, compared to 53% and 43% for Ni(II)2•Gly-Gly-His-(δ)-Orn-Gly-His and 
Ni(II)•Gly-Gly-His, respectively. While this increased efficiency may simply be due to the 
greater capacity of the oligomeric system to interact with the target DNA relative to the 
monomeric system (as also noted during modelling), more importantly this result confirms 
that the environment provided by tandem-linked Orn-Gly-His units remains conducive to 
activation and substrate oxidative modification and that the oligomeric systems might 
function more efficiently than monomeric Gly-Gly-His upon conjugation to other entities.
CONCLUSIONS
Tandem-linked units of (δ)-Orn-Gly-His peptides can be synthesized conveniently through 
standard Fmoc solid phase methodologies and bind Cu, Ni, and Co in linear arrays that 
achieve full stoichiometric occupancy of the available Gly-Gly-His-like metal binding sites. 
While oligopeptides that specifically contain between two and four metal binding units were 
examined herein, the procedures employed, and the metallation propensities observed, 
appear amenable to the generation of longer metallated oligomers. Further, each tandem-
linked (δ)-Orn-Gly-His unit appears to bind to a metal in a fashion similar to an amino-
terminal Gly-Gly-His motif and individual (δ)-Orn-Gly-His sequences. Thus, like their 
monomeric counterparts, these multi-metallated systems may find utility in the development 
of bioconjugates with increased capacity to modify a bound substrate.
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Fig. (1). 
Structure of M(II)•Gly-Gly-His and illustration of the (δ)-Orn strategy to permit the 
transformation of amino-terminal Gly-Gly-His metal binding motifs into a metal binding 
system that can be placed at any location in a peptide or in tandem arrays; Orn substitution 
for Gly1 (top) shown in bold.
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Fig. (2). 
Top panels: Titrations of 1 mM solutions of peptide 4 (containing 4 metal binding sites) 
with Cu2+ (left) and Ni2+ (right) monitored by UV-vis spectroscopy. Titrations in these top 
panels illustrate the increasing absorbance observed upon the addition of 0.4 equivalents of 
metal ion (per increment of addition) up to four total equivalents (relative to peptide 4). 
Each black spectrum in the left and right top panels illustrates the absorbance increase 
observed upon a 0.4 equivalent addition of metal ion (Cu or Ni). The lowest black 
absorbance spectrum represents the absorbance observed upon the addition of 0.4 
equivalents of added metal, the next highest black spectrum represents the addition of 0.8 
equivalents of added metal, the next black spectrum represents the addition of 1.2 
equivalents, etc. In total, there are 10 stacked black spectra (10 × 0.4 equivalents = 4 total 
equivalents of added metal). Given that each peptide 4 contains 4 metal binding sites, a 1 
mM solution of 4 contains 4 mM metal binding sites, thus requiring 4 full equivalents of 
added metal ion (relative to peptide) to achieve binding saturation, as observed. The green 
absorbance spectrum in each top panel (overlapping with the black spectrum of highest 
absorbance) illustrates the absorbance observed upon addition of one further full equivalent 
of metal ion (4:M2+ = 1:5); no further increase in absorbance was observed, metal binding 
saturation was achieved upon 4 added equivalents. For comparison, the red absorbance 
superimposed on each plot illustrates the absorbance observed from a 1:1 mixture of 
Cu(II)•1 or Ni(II)•1 (1 mM). Middle panels: UV-Vis titrations of peptides 1–4 with Cu2+ 
(left) and Ni2+ (right). Titrations illustrate the increasing absorbance observed at 525 nm 
(Cu) or 420 nm (Ni) upon the addition of 0.4 equivalents of metal ion per increment of 
addition (black: 1; red: 2; green: 3; blue: 4); breakpoints in each titration occur upon 
saturation of each metal binding site. Bottom panels: UV-visible absorbance analysis of 
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peptide 4 (left) in the presence of one (red), two, three, four, or five (green) equivalents of 
Co and titrations of peptides 1–4 with Co (right): black, 1; red, 2; green, 3; and blue, 4). In 
each case, Co2+ binding was followed by in situ generation of Co(III)-metallated peptides 
prior to spectroscopic analysis.
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Fig. (3). 
ESI-MS analysis of Cu(II)-bound peptide 4 at a ratio of Cu2+ to metal binding site of 3:4. 
The expansion shown illustrates the predicted isotopic distribution for one bound equivalent 
of Cu to 4.
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Fig. (4). 
Molecular models representing the average structure of Ni(II)4•Gly-Gly-His-(δ)-Orn-Gly-
His-(δ)-Orn-Gly-His-(δ)-Orn-Gly-His determined by MD simulations.
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Fig. (5). 
Analysis of the DNA cleavage activity of Ni(II)•Gly-Gly-His, Ni(II)2•Gly-Gly-His-(δ)-Orn-
Gly-His and Ni(II)3•Gly-Gly-His-(δ)-Orn-Gly-His-(δ)-Orn-Gly-His. All reactions contained 
30 μM ΦX174 RF DNA (base pair concentration) in 10 mM Na-cacodylate buffer, pH 7.5. 
Lane 1: reaction control, DNA alone; Lane 2: reaction control, DNA, 30 μM Ni2+, 30 μM 
KHSO5; Lane 3: reaction control, DNA, 30 μM KHSO5, 30 μM Gly-Gly-His; Lane 4: 
reaction control, DNA, 30 μM KHSO5, 15 μM Gly-Gly-His-(δ)-Orn-Gly-His; Lane 5: 
reaction control, DNA, 30 μM KHSO5, 10 μM Gly-Gly-His-(δ)-Orn-Gly-His-(δ)-Orn-Gly-
His; Lane 6: 30 μM Ni2+, 30 μM KHSO5, 30 μM Gly-Gly-His; Lane 7: 30 μM Ni2+, 30 μM 
KHSO5, 15 μM Gly-Gly-His-(δ)-Orn-Gly-His; Lane 8: 30 μM Ni2+, 30 μM KHSO5, 10 μM 
Gly-Gly-His-(δ)-Orn-Gly-His-(δ)-Orn-Gly-His.
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